Dimitrios Christodoulou

Author

Also Known As

Alessandro Armuzzi, Christodoulou D, Christodoulou Dimitrios, Christodoulou, Dimitrios, Christos Triantos, D CHRISTODOULOU, D Christodoulou, D K Christodoulou, D. Christodoulou, D. K. Christodoulou

348

Publications

5.2K

Citations

H-Index

126

Concepts

All Affiliations

University of Ioannina University Hospital of Ioannina Mater Dei Hospital Hospital de São João Tel Aviv University

About

Dimitrios Christodoulou is an author at University of Ioannina specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	983
2	Engineering	5	5	92
3	Business	1	1	12
4	Education	1	1	21
5	Health Sciences	1	1	87

Dimitrios Christodoulou

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study Johan Burisch, Gediminas Kiudelis, Limas Kupčinskas, Gut	2018	281
Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline Κonstantinos Τriantafyllou, Paraskevas Gkolfakis, Ian M. Gralnek, Endoscopy	2021	194
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study Johan Burisch, Dimitrios Christodoulou, Luísa Leite Barros, Journal of Crohn s and Colitis	2018	160
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study Johan Burisch, Hillel Vardi, Doron Schwartz, The Lancet. Gastroenterology & hepatology	2020	152
A new minimally invasive treatment of pilonidal sinus disease with the use of a diode laser: a prospective large series of patients Alexandros Pappas, Dimitrios Christodoulou Colorectal Disease	2018	121
Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: A prospective single-center study Taxiarchis Felekis, Margarita Kitsanou, Vasileios Theopistos, Inflammatory Bowel Diseases	2008	117
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies Konstantinos Papamichael, Joseph D. Feuerstein, Dimitrios Christodoulou, Clinical Immunology InflammationAnti-inflammatoryImmunologyGastroenterologyPathology	2018	95
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt, The Lancet. Gastroenterology & hepatology InflammationAnti-inflammatoryImmunologyGastroenterologyMaintenance Therapy	2021	89
von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia Georgios Kalambokis, Aikaterini Oikonomou, Leonidas Christou, Journal of Hepatology ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseHepatology	2016	87
A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates N. Viazis, Konstantinos Argyriou, Katerina Kotzampassi, Nutrients Four-probiotics Regimen CombinedDysbiosisGastroenterologyPharmacotherapyProbiotics	2022	82

Page 1